Chris Conrad

987 total citations
9 papers, 765 citations indexed

About

Chris Conrad is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Chris Conrad has authored 9 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Chris Conrad's work include Alzheimer's disease research and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Ubiquitin and proteasome pathways (2 papers). Chris Conrad is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Ubiquitin and proteasome pathways (2 papers). Chris Conrad collaborates with scholars based in United States, Japan and Germany. Chris Conrad's co-authors include Eliezer Masliah, Leon J. Thal, Yu Xia, Peter Davies, Tsunao Saitoh, Athena Andreadis, Melissa Freeman, John Q. Trojanowski, Robert Katzman and Dennis W. Dickson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Annals of Neurology.

In The Last Decade

Chris Conrad

9 papers receiving 753 citations

Peers

Chris Conrad
Elie Needle United States
Christopher J. Holler United States
Carl D. Gajewski United States
Tuancheng Feng United States
Jillian H. Kluss United States
Preston Ge United States
Lara Wahlster United States
WonHee Kim United States
Elie Needle United States
Chris Conrad
Citations per year, relative to Chris Conrad Chris Conrad (= 1×) peers Elie Needle

Countries citing papers authored by Chris Conrad

Since Specialization
Citations

This map shows the geographic impact of Chris Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Conrad more than expected).

Fields of papers citing papers by Chris Conrad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Conrad. The network helps show where Chris Conrad may publish in the future.

Co-authorship network of co-authors of Chris Conrad

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Conrad. A scholar is included among the top collaborators of Chris Conrad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Conrad. Chris Conrad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Landrette, Sean F., Neil Beeharry, Chris Conrad, et al.. (2017). Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma. Blood. 129(13). 1768–1778. 140 indexed citations
2.
Landrette, Sean F., Neil Beeharry, Chris Conrad, et al.. (2017). B-cell non-Hodgkin lymphoma: Selective vulnerability to PIKFYVE inhibition. Autophagy. 13(6). 1082–1083. 13 indexed citations
3.
Conrad, Chris, Jun Zhu, David A. Schoenfeld, et al.. (2007). Single molecule profiling of tau gene expression in Alzheimer’s disease. Journal of Neurochemistry. 103(3). 1228–1236. 58 indexed citations
4.
Conrad, Chris, Dietmar Rudolf Thal, Estifanos Ghebremedhin, et al.. (2004). Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease. Journal of Neurochemistry. 89(1). 179–188. 34 indexed citations
5.
Conrad, Chris, et al.. (2002). A polymorphic gene nested within an intron of the tau gene: Implications for Alzheimer's disease. Proceedings of the National Academy of Sciences. 99(11). 7751–7756. 96 indexed citations
6.
Xia, Yu, Tsunao Saitoh, Kenji Uéda, et al.. (2001). Characterization of the human α-synuclein gene: Genomic structure, transcription start site, promoter region and polymorphisms. Journal of Alzheimer s Disease. 3(5). 485–494. 44 indexed citations
7.
Conrad, Chris, Naoji Amano, Athena Andreadis, et al.. (1998). Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy. Neuroscience Letters. 250(2). 135–137. 35 indexed citations
8.
Hashimoto, Makoto, Satoshi Inoue, Sumito Ogawa, et al.. (1998). Rapid Fragmentation of Vimentin in Human Skin Fibroblasts Exposed to Tamoxifen: A Possible Involvement of Caspase-3. Biochemical and Biophysical Research Communications. 247(2). 401–406. 33 indexed citations
9.
Conrad, Chris, Athena Andreadis, John Q. Trojanowski, et al.. (1997). Genetic evidence for the involvement of τ in progressive supranuclear palsy. Annals of Neurology. 41(2). 277–281. 312 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026